Mobile App for Improving Adherence of Rivoxaban (RIVOX-AF)
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 637 participants.
Also called NCT05557123
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 637 participants
- Registry
-
NCT05557123
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT05557123. Randomized; no masking; primary purpose treatment. Start 2022-03-10 (actual); primary completion 2025-12-16 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Mobile App for Improving Adherence of Rivoxaban (RIVOX-AF)
- Condition
- Atrial Fibrillation
- Intervention (Device)
- MEDI-app
- Lead sponsor
- Seoul National University Bundang Hospital
- Collaborator
- SAMJIN PHARM
Record details
- Record id
cardio:ct-nct05557123- Content hash
633b059a9b47710cb3f059cf7c7ad9c808d249e4e8a775c4fa01c39165954ead